(Q38183288)

30 August 2017

title

MicroRNAs in neuroblastoma: small-sized players with a large impact (English)

1 reference

30 August 2017

1 reference

1 reference

Feng Zhi

1

1 reference

30 August 2017

Rong Wang

2

1 reference

30 August 2017

Qiang Wang

3

1 reference

30 August 2017

Lian Xue

4

1 reference

30 August 2017

Danni Deng

5

1 reference

30 August 2017

Suinuan Wang

6

1 reference

30 August 2017

Yilin Yang

7

1 reference

30 August 2017

language of work or name

1 reference

30 January 2014

1 reference

30 August 2017

published in

Neurochemical Research

1 reference

30 August 2017

volume

39

1 reference

30 August 2017

issue

4

1 reference

30 August 2017

page(s)

613-623

1 reference

https://scigraph.springernature.com/pub.10.1007/s11064-014-1247-9

30 August 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Recent advances in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Non-coding RNAs in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNA signatures in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

miRBase: integrating microRNA annotation and deep-sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNA maturation: stepwise processing and subcellular localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNAs: small RNAs with a big role in gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MYCN regulates oncogenic MicroRNAs in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: association of miRNA expression with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

miRNA expression profiling enables risk stratification in archived and fresh neuroblastoma tumor samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

microRNA signature and expression of Dicer and Drosha can predict prognosis and delineate risk groups in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Identification of miRNAs that are associated with tumor metastasis in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

The MYCN oncogene is a direct target of miR-34a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Reduced levels of miR-34a in neuroblastoma are not caused by mutations in the TP53 binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

The interplay between microRNAs and the neurotrophin receptor tropomyosin-related kinase C controls proliferation of human neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MiR-27b targets PPARγ to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MIR152, MIR200B, and MIR338, human positional and functional neuroblastoma candidates, are involved in neuroblast differentiation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNA miR-885-5p targets CDK2 and MCM5, activates p53 and inhibits proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Down-regulation of miR-17 family expression in response to retinoic acid induced neuronal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNA-125b promotes neuronal differentiation in human cells by repressing multiple targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

miR-7 and miR-214 are specifically expressed during neuroblastoma differentiation, cortical development and embryonic stem cells differentiation, and control neurite outgrowth in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNAs 10a and 10b are potent inducers of neuroblastoma cell differentiation through targeting of nuclear receptor corepressor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Inhibition of mir-21, which is up-regulated during MYCN knockdown-mediated differentiation, does not prevent differentiation of neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

A new module in neural differentiation control: two microRNAs upregulated by retinoic acid, miR-9 and -103, target the differentiation inhibitor ID2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Tumour-suppressor microRNAs let-7 and mir-101 target the proto-oncogene MYCN and inhibit cell proliferation in MYCN-amplified neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

The role of miR-103 and miR-107 in regulation of CDK5R1 expression and in cellular migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNA-542-5p as a novel tumor suppressor in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Accurate prediction of neuroblastoma outcome based on miRNA expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Circulating microRNAs as stable blood-based markers for cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Alterations in expression of specific microRNAs by combination of 4-HPR and EGCG inhibited growth of human malignant neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

Overexpression of miR-7-1 increases efficacy of green tea polyphenols for induction of apoptosis in human malignant neuroblastoma SH-SY5Y and SK-N-DZ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11064-014-1247-9

MicroRNA-15a promotes neuroblastoma migration by targeting reversion-inducing cysteine-rich protein with Kazal motifs (RECK) and regulating matrix metalloproteinase-9 expression

21 January 2018

1 reference

12 December 2020

A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.

1 reference

12 December 2020

MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma

1 reference

12 December 2020

miR-149* induces apoptosis by inhibiting Akt1 and E2F1 in human cancer cells

1 reference

12 December 2020

Identification and characterization of microRNAs in raw milk during different periods of lactation, commercial fluid, and powdered milk products

1 reference

12 December 2020

MicroRNAs in cancer - from research to therapy

1 reference

12 December 2020

10.1007/S11064-014-1247-9

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1022077809

0 references

1 reference